ICICI Prudential Life Reports Mixed Q3 FY24-25 Results Amidst Profit Growth and Sales Decline
ICICI Prudential Life Insurance Company reported its third-quarter financial results for FY24-25, highlighting a significant increase in Profit Before Tax and Profit After Tax, alongside a peak in Earnings per Share. However, the company faced challenges with a sharp decline in net sales and reduced cash reserves, indicating a mixed performance.
ICICI Prudential Life Insurance Company has released its financial results for the third quarter of FY24-25, showcasing a complex landscape. The company's Profit Before Tax (PBT) reached Rs 241.29 crore, reflecting a notable year-on-year growth of 255.81%. In addition, the Profit After Tax (PAT) was reported at Rs 324.91 crore, which is a 43.2% increase year-on-year and marks the highest PAT recorded in the last five quarters. The Earnings per Share (EPS) also peaked at Rs 2.25, suggesting enhanced profitability for shareholders.On the other hand, the company encountered significant challenges, with net sales declining sharply to Rs 4,536.44 crore, representing a year-on-year drop of 82.84% and the lowest sales figure in the last five quarters. Moreover, non-operating income constituted 41.18% of PBT, which raises questions about the sustainability of its business model. The company's cash and cash equivalents fell to Rs 99.28 crore, indicating a tightening of short-term liquidity. Overall, ICICI Prudential Life's financial results reflect a mixed assessment for the quarter.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
